Goldman Sachs’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20.9M | Buy |
1,628,241
+172,622
| +12% | +$2.2M | ﹤0.01% | 2394 |
|
|
2025
Q4 | $13.1M | Sell |
1,455,619
-2,823,058
| -66% | -$38.9M | ﹤0.01% | 2814 |
|
|
2025
Q3 | $73.9M | Buy |
4,278,677
+2,231,429
| +109% | +$27.5M | 0.01% | 1136 |
|
|
2025
Q2 | $19.2M | Sell |
2,047,248
-365,935
| -15% | -$3.01M | ﹤0.01% | 2168 |
|
|
2025
Q1 | $17.2M | Buy |
2,413,183
+378,399
| +19% | +$3.82M | ﹤0.01% | 2167 |
|
|
2024
Q4 | $23.7M | Buy |
2,034,784
+1,000,303
| +97% | +$15.6M | ﹤0.01% | 1955 |
|
|
2024
Q3 | $21.3M | Sell |
1,034,481
-232,121
| -18% | -$5.35M | ﹤0.01% | 2014 |
|
|
2024
Q2 | $28.3M | Buy |
1,266,602
+199,142
| +19% | +$4.74M | 0.01% | 1588 |
|
|
2024
Q1 | $29.4M | Buy |
1,067,460
+242,933
| +29% | +$6.75M | 0.01% | 1544 |
|
|
2023
Q4 | $25.1M | Buy |
824,527
+28,264
| +4% | +$812K | 0.01% | 1696 |
|
|
2023
Q3 | $25.2M | Sell |
796,263
-207,503
| -21% | -$8.05M | 0.01% | 1603 |
|
|
2023
Q2 | $40.9M | Buy |
1,003,766
+144,284
| +17% | +$5.85M | 0.01% | 1253 |
|
|
2023
Q1 | $32M | Buy |
859,482
+232,388
| +37% | +$9.11M | 0.01% | 1386 |
|
|
2022
Q4 | $21.9M | Sell |
627,094
-354,661
| -36% | -$16.9M | 0.01% | 1873 |
|
|
2022
Q3 | $54.9M | Buy |
981,755
+133,572
| +16% | +$8.29M | 0.02% | 1059 |
|
|
2022
Q2 | $43.9M | Buy |
848,183
+317,167
| +60% | +$16.1M | 0.01% | 1221 |
|
|
2022
Q1 | $38.6M | Sell |
531,016
-460,075
| -46% | -$39M | 0.01% | 1508 |
|
|
2021
Q4 | $117M | Buy |
991,091
+20,801
| +2% | +$2.61M | 0.03% | 718 |
|
|
2021
Q3 | $130M | Sell |
970,290
-25,862
| -3% | -$3.92M | 0.03% | 606 |
|
|
2021
Q2 | $161M | Buy |
996,152
+214,067
| +27% | +$16.7M | 0.04% | 490 |
|
|
2021
Q1 | $62.8M | Sell |
782,085
-276,527
| -26% | -$18.6M | 0.02% | 981 |
|
|
2020
Q4 | $57.6M | Buy |
1,058,612
+518,520
| +96% | +$18.8M | 0.02% | 1021 |
|
|
2020
Q3 | $10.7M | Buy |
540,092
+414,377
| +330% | +$8.64M | ﹤0.01% | 2263 |
|
|
2020
Q2 | $2.64M | Buy |
125,715
+32,759
| +35% | +$557K | ﹤0.01% | 3262 |
|
|
2020
Q1 | $1.14M | Sell |
92,956
-506
| -0.5% | -$6.82K | ﹤0.01% | 3666 |
|
|
2019
Q4 | $1.37M | Sell |
93,462
-59,140
| -39% | -$823K | ﹤0.01% | 3918 |
|
|
2019
Q3 | $2.04M | Sell |
152,602
-68,281
| -31% | -$1.09M | ﹤0.01% | 3516 |
|
|
2019
Q2 | $3.62M | Buy |
220,883
+85,832
| +64% | +$1.35M | ﹤0.01% | 3095 |
|
|
2019
Q1 | $2.31M | Sell |
135,051
-26,880
| -17% | -$401K | ﹤0.01% | 3546 |
|
|
2018
Q4 | $2.21M | Buy |
161,931
+64,134
| +66% | +$1.19M | ﹤0.01% | 3466 |
|
|
2018
Q3 | $2.8M | Buy |
97,797
+10,711
| +12% | +$312K | ﹤0.01% | 3369 |
|
|
2018
Q2 | $2.38M | Buy |
87,086
+54,326
| +166% | +$1.32M | ﹤0.01% | 3523 |
|
|
2018
Q1 | $691K | Sell |
32,760
-97,140
| -75% | -$2.39M | ﹤0.01% | 4282 |
|
|
2017
Q4 | $2.5M | Buy |
129,900
+97,936
| +306% | +$2.26M | ﹤0.01% | 3601 |
|
|
2017
Q3 | $794K | Sell |
31,964
-16,602
| -34% | -$313K | ﹤0.01% | 4773 |
|
|
2017
Q2 | $777K | Buy |
48,566
+7,866
| +19% | +$110K | ﹤0.01% | 4700 |
|
|
2017
Q1 | $573K | Sell |
40,700
-122,003
| -75% | -$1.64M | ﹤0.01% | 4884 |
|
|
2016
Q4 | $2.13M | Buy |
162,703
+6,512
| +4% | +$97.8K | ﹤0.01% | 3800 |
|
|
2016
Q3 | $2.66M | Buy |
156,191
+12,189
| +8% | +$236K | ﹤0.01% | 3583 |
|
|
2016
Q2 | $3.07M | Buy |
+144,002
| New | +$3.83M | ﹤0.01% | 3246 |
|
Other funds holding NTLA
AIM
VPM
VCM
RP
